Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Non-cash Items (2016 - 2026)

Gyre Therapeutics has reported Non-cash Items over the past 15 years, most recently at $15.9 million for Q4 2025.

  • Quarterly Non-cash Items fell 91.63% to $15.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.9 million through Dec 2025, down 91.63% year-over-year, with the annual reading at $15.9 million for FY2025, 8.69% down from the prior year.
  • Non-cash Items was $15.9 million for Q4 2025 at Gyre Therapeutics, up from $15.1 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $444.2 million in Q4 2023 and troughed at $100000.0 in Q1 2024.
  • The 5-year median for Non-cash Items is $7.4 million (2023), against an average of $38.4 million.
  • Year-over-year, Non-cash Items tumbled 98.63% in 2024 and then soared 10700.0% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $3.9 million in 2021, then soared by 224.79% to $12.7 million in 2022, then skyrocketed by 3406.73% to $444.2 million in 2023, then crashed by 57.14% to $190.4 million in 2024, then tumbled by 91.63% to $15.9 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Non-cash Items are $15.9 million (Q4 2025), $15.1 million (Q3 2025), and $15.6 million (Q2 2025).